NIT Rourkela Patents Pumpkin Petal-Silk Protein Formulation for Skin Cancer Treatment

Published On 2025-09-24 12:01 GMT   |   Update On 2025-09-24 12:01 GMT
Advertisement

Bhubaneswar: In a significant scientific development, researchers at the National Institute of Technology (NIT) Rourkela have patented a novel formulation for the treatment of skin cancer, developed from an unusual yet powerful combination of pumpkin petal extracts and silk proteins.

As per a recent media report in The Times of India, the formulation harnesses the natural antioxidant and anti-cancer properties of pumpkin petals, while silk proteins provide exceptional biocompatibility and structural strength. To enhance effectiveness, the team has incorporated a nanofiber-based delivery system, allowing precise targeting of cancerous cells and minimizing toxic side effects often associated with conventional treatments.

Advertisement

According to the researchers, this innovation is not only eco-friendly and sustainable but also holds the potential to serve as a cost-effective alternative for millions of patients battling skin cancer. The patented technology has already undergone several stages of validation, paving the way for further development toward clinical application.

Times of India reports that this patent marks a major step forward in leveraging natural resources and advanced biomaterials to design therapies that could transform cancer care in India and beyond.

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News